Go Pro
NASDAQ:CEROW

CERo Therapeutics 9/2/2026 Earnings Report

$0.0025 0.00 (0.00%)
As of 08/5/2026 03:30 PM Eastern

CERo Therapeutics EPS Results

Actual EPS
N/A
Consensus EPS
-$0.80
Beat/Miss
N/A
One Year Ago EPS
N/A

CERo Therapeutics Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

CERo Therapeutics Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

CERo Therapeutics Earnings Headlines

No headlines for this company have been tracked by MarketBeat.com
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like CERo Therapeutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on CERo Therapeutics and other key companies, straight to your email.

About CERo Therapeutics

CERo Therapeutics (NASDAQ:CEROW), an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies. The company was incorporated in 2021 and is based in South San Francisco, California.

View CERo Therapeutics Profile